Symbol="ALNY"
AssetType="Common Stock"
Name="Alnylam Pharmaceuticals Inc"
Description="Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts."
CIK="1178670"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23621337000"
EBITDA="-739073984"
PERatio="None"
PEGRatio="-0.49"
BookValue="-2.087"
DividendPerShare="0"
DividendYield="0"
EPS="-8.7"
RevenuePerShareTTM="9.32"
ProfitMargin="-0.931"
OperatingMarginTTM="-0.689"
ReturnOnAssetsTTM="-0.144"
ReturnOnEquityTTM="-15.01"
RevenueTTM="1143449000"
GrossProfitTTM="868601000"
DilutedEPSTTM="-8.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.497"
AnalystTargetPrice="249.95"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.37"
PriceToBookRatio="142.92"
EVToRevenue="28.64"
EVToEBITDA="-29.42"
Beta="0.478"
num_52WeekHigh="242.97"
num_52WeekLow="135.46"
num_50DayMovingAverage="196.63"
num_200DayMovingAverage="207.16"
SharesOutstanding="124526000"
DividendDate="None"
ExDividendDate="None"
symbol="ALNY"
open="190.00"
high="194.40"
low="189.06"
price="192.57"
volume="329521.00"
latest_trading_day="2023-07-05"
previous_close="189.69"
change="2.88"
change_percent="1.5183%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="74"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="717058"
Change_recent_avg="-0.12"
Delta_recent_avg="5.85"
Variance_recent_avg="2.92"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="510"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_negative_thumbnail_id_2="110"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0066.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="704"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_positive_thumbnail_id_2="612"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0096.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
